Atorvastatin Attenuates Cardiomyocyte Loss in Adult Rats From Protein-Restricted Dams

Journal of Cardiac Failure

Volumn 14, Issue 2, 2008, Pages 151-160

  Bezerra, Daniele Gonçalves ^a   Lacerda Andrade, Lívia Marinho ^a   Pinto da Cruz, Fernanda Ornellas ^a   Mandarim de Lacerda, Carlos Alberto ^a  

^a Biology Institute   (Brazil)

Author keywords

Cardiac remodeling; heart failure prevention; metabolic programming; statins; stereology

Indexed keywords

ATORVASTATIN; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CELL LOSS; CELL SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; LOW DRUG DOSE; MALE; NEWBORN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN RESTRICTION; RAT; VASCULARIZATION;

ANIMALS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOMEGALY; DIET, PROTEIN-RESTRICTED; FIBROSIS; HEPTANOIC ACIDS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL REPERFUSION; MYOCYTES, CARDIAC; PERFUSION; PYRROLES; RATS; RATS, WISTAR;

EID: 39749197432     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.10.015     Document Type: Article

References (86)

1. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998) 1129-1135
2. Jialal I., Stein D., Balis D., Grundy S.M., Adams-Huet B., and Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103 (2001) 1933-1935
3. Wagner A.H., Kohler T., Ruckschloss U., Just I., and Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscl Thromb Vasc Biol 20 (2000) 61-69
4. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
5. Rosenson R.S., and Tangney C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279 (1998) 1643-1650
6. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
7. Bravo L., Herrera M.D., Marhuenda E., and Perez-Guerrero C. Cardiovascular effects of lovastatin in normotensive and spontaneously hypertensive rats. Gen Pharmacol 30 (1998) 331-336
8. Susic D., Varagic J., Ahn J., Slama M., and Frohlich E.D. Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models. J Amer Coll Cardiol 42 (2003) 1091-1097
9. Paniagua J.A., Lopez-Miranda J., Escribano A., et al. Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes. Diabetes 51 (2002) 2596-2603
10. Wong V., Stavar L., Szeto L., et al. Atorvastatin induces insulin sensitization in Zucker lean and fatty rats. Atherosclerosis 184 (2006) 348-355
11. Weber K.T. Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation 102 (2000) 1342-1345
12. Anversa P., and Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 415 (2002) 240-243
13. Brilla C.G. Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovasc Res 47 (2000) 1-3
14. Reddy R., Chahoud G., and Mehta J.L. Modulation of cardiovascular remodeling with statins: fact or fiction?. Curr Vasc Pharmacol 3 (2005) 69-79
15. Scalia R., and Stalker T.J. Microcirculation as a target for the anti-inflammatory properties of statins. Microcirculation 9 (2002) 431-442
16. Barker D.J. In utero programming of chronic disease. Clin Sci (Lond) 95 (1998) 115-128
17. Phillips D.I. Birth weight and the future development of diabetes. A review of the evidence. Diabetes care 21 Suppl 2 (1998) B150-B155
18. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
19. Langley-Evans S.C., Gardner D.S., and Jackson A.A. Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J Nutr 126 (1996) 1578-1585
20. Wainwright P.E. Issues of design and analysis relating to the use of multiparous species in developmental nutritional studies. J Nutr 128 (1998) 661-663
21. Quinn R. Comparing rat's to human's age: how old is my rat in people years?. Nutrition 21 (2005) 775-777
22. Larsson L., Aperia A., and Wilton P. Effect of normal development on compensatory renal growth. Kidney Int 18 (1980) 29-35
23. Yin F.C., Spurgeon H.A., Rakusan K., Weisfeldt M.L., and Lakatta E.G. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 243 (1982) H941-H947
24. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26 (1970) 57-63
25. Weibel E.R. Stereological methods. Practical methods for biological morphometry (1979), Academic Press, London
26. Mandarim-de-Lacerda C.A. Stereological tools in biomedical research. An Acad Bras Cienc 75 (2003) 469-486
27. Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc 134 (1984) 127-136
28. Cruz-Orive L.M., and Weibel E.R. Recent stereological methods for cell biology: a brief survey. Am J Physiol 258 (1990) L148-L156
29. Woods L.L., Weeks D.A., and Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int 65 (2004) 1339-1348
30. Almeida J.R., and Mandarim-de-Lacerda C.A. Overweight is gender-dependent in prenatal protein-calorie restricted adult rats acting on the blood pressure and the adverse cardiac remodeling. Life Sci 77 (2005) 1307-1318
31. Ozanne S.E., and Hales C.N. The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proceed Nutr Soc 58 (1999) 615-619
32. Catta-Preta M., Oliveira D.A., Mandarim-de-Lacerda C.A., and Aguila M.B. Adult cardiorenal benefits from postnatal fish oil supplement in rat offspring of low-protein pregnancies. Life Sci 80 (2006) 219-229
33. Bezerra D.G., and Mandarim-de-Lacerda C.A. Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats. Clin Sci (Lond) 108 (2005) 349-355
34. Dechend R., Fiebeler A., Park J.K., et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation 104 (2001) 576-581
35. Strazzullo P., Kerry S.M., Barbato A., Versiero M., D'Elia L., and Cappuccio F.P. Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension 49 (2007) 792-798
36. Bendall J.K., Cave A.C., Heymes C., Gall N., and Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105 (2002) 293-296
37. Maack C., Kartes T., Kilter H., et al. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108 (2003) 1567-1574
38. Habibi J., Whaley-Connell A., Qazi M.A., et al. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology 148 (2007) 2181-2188
39. Nakata M., Nagasaka S., Kusaka I., Matsuoka H., Ishibashi S., and Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia 49 (2006) 1881-1892
40. Ye Y., Lin Y., Atar S., et al. Myocardial protection by pioglitazone, atorvastatin and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol 291 (2006) H1158-H1169
41. Atar S., Ye Y., Lin Y., et al. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol 290 (2006) H1960-H1968
42. Hayashidani S., Tsutsui H., Shiomi T., et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 105 (2002) 868-873
43. Saka M., Obata K., Ichihara S., et al. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure. J Cardiovasc Pharmacol 47 (2006) 770-779
44. Ii M., and Losordo D.W. Statins and the endothelium. Vascul Pharmacol 46 (2007) 1-9
45. Hindler K., Cleeland C.S., Rivera E., and Collard C.D. The role of statins in cancer therapy. Oncologist 11 (2006) 306-315
46. Anversa P., Olivetti G., and Loud A.V. Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. I. Hypertrophy, hyperplasia, and binucleation of myocytes. Circ Res 46 (1980) 495-502
47. Austin A., Fagan D.G., and Mayhew T.M. A stereological method for estimating the total number of ventricular myocyte nuclei in fetal and postnatal hearts. J Anat 187 (1995) 641-647
48. Mandarim-de-Lacerda C.A., and Pessanha M.G. Stereology of the myocardium in embryos, fetuses and neonates of the rat. Acta Anat (Basel) 154 (1995) 261-266
49. Mandarim-de-Lacerda C.A., Santos M.B., Le Floch-Prigent P., and Narcy F. Stereology of the myocardium in human foetuses. Early Hum Develop 48 (1997) 249-259
50. Li F., Wang X., Capasso J.M., and Gerdes A.M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28 (1996) 1737-1746
51. Chacko S. DNA synthesis, mitosis, and differentiation in cardiac myogenesis. Dev Biol 35 (1973) 1-18
52. Anversa P., and Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 83 (1998) 1-14
53. Wulfsohn D., Nyengaard J.R., and Tang Y. Postnatal growth of cardiomyocytes in the left ventricle of the rat. Anat Rec A Discov Mol Cell Evol Biol 277 (2004) 236-247
54. Olivetti G., Melissari M., Capasso J.M., and Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68 (1991) 1560-1568
55. Kajstura J., Cheng W., Sarangarajan R., et al. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 271 (1996) H1215-H1228
56. Kajstura J., Bolli R., Sonnenblick E.H., Anversa P., and Leri A. Cause of death: suicide. J Mol Cell Cardiol 40 (2006) 425-437
57. Engel F.B. Cardiomyocyte proliferation: a platform for mammalian cardiac repair. Cell Cycle 4 (2005) 1360-1363
58. Di Napoli P., Taccardi A.A., Grilli A., et al. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. Am Heart J 146 (2003) 1105-1111
59. Olivetti G., Giordano G., Corradi D., et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 26 (1995) 1068-1079
60. Corstius H.B., Zimanyi M.A., Maka N., et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 57 (2005) 796-800
61. Cheema K.K., Dent M.R., Saini H.K., Aroutiounova N., and Tappia P.S. Prenatal exposure to maternal undernutrition induces adult cardiac dysfunction. Br J Nutr 93 (2005) 471-477
62. Seckl J.R. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 62 (1997) 89-94
63. Langley-Evans S.C., and Nwagwu M. Impaired growth and increased glucocorticoid-sensitive enzyme activities in tissues of rat fetuses exposed to maternal low protein diets. Life Sci 63 (1998) 605-615
64. Burniston J.G., Saini A., Tan L.B., and Goldspink D.F. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol 39 (2005) 395-399
65. Woods L.L., Ingelfinger J.R., Nyengaard J.R., and Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49 (2001) 460-467
66. Jiang L., Huang Y., Hunyor S., and dos Remedios C.G. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J 24 (2003) 742-751
67. Mandarim-de-Lacerda C.A., and Pereira L.M.M. Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition. Pathobiology 68 (2000) 36-42
68. Tousoulis D., Charakida M., Stefanadi E., Siasos G., Latsios G., and Stefanadis C. Statins in heart failure. Beyond the lipid lowering effect. Int J Cardiol 115 (2007) 144-150
69. Bergmann M.W., Rechner C., Freund C., Baurand A., El Jamali A., and Dietz R. Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin. J Mol Cell Cardiol 37 (2004) 681-690
70. Anversa P., Rota M., Urbanek K., et al. Myocardial aging-a stem cell problem. Basic Res Cardiol 100 (2005) 482-493
71. Barile L., Chimenti I., Gaetani R., et al. Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S9-S14
72. Torella D., Ellison G.M., Karakikes I., and Nadal-Ginard B. Growth-factor-mediated cardiac stem cell activation in myocardial regeneration. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S46-S51
73. Tateishi K., Ashihara E., Takehara N., et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci 120 (2007) 1791-1800
74. Aguila M.B., and Mandarim-de-Lacerda C.A. Blood pressure, ventricular volume and number of cardiomyocyte nuclei in rats fed for 12 months on diets differing in fat composition. Mech Ageing Dev 122 (2001) 77-88
75. Aguila M.B., Pinheiro A.R., and Mandarim-de-Lacerda C.A. Spontaneously hypertensive rats left ventricular cardiomyocyte loss attenuation through different edible oils long-term intake. Int J Cardiol 100 (2005) 461-466
76. Gonzalez A., Fortuno M.A., Querejeta R., et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 59 (2003) 549-562
77. Tan L.B., Burniston J.G., Clark W.A., Ng Y., and Goldspink D.F. Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agents: toward a new bioassay for beta-blockers. J Cardiovasc Pharmacol 41 (2003) 518-525
78. Goldspink D.F., Burniston J.G., Ellison G.M., Clark W.A., and Tan L.B. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?. Exp Physiol 89 (2004) 407-416
79. Ozanne S.E., Wang C.L., Dorling M.W., and Petry C.J. Dissection of the metabolic actions of insulin in adipocytes from early growth-retarded male rats. J Endocrinol 162 (1999) 313-319
80. Hales C.N., and Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35 (1992) 595-601
81. Robinson S.M., Wheeler T., Hayes M.C., Barker D.J., and Osmond C. Fetal heart rate and intrauterine growth. Brit J Obstet Gynecol 98 (1991) 1223-1227
82. Jansson T., and Lambert G.W. Effect of intrauterine growth restriction on blood pressure, glucose tolerance and sympathetic nervous system activity in the rat at 3-4 months of age. J Hypert 17 (1999) 1239-1248
83. Takemoto M., Node K., Nakagami H., et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108 (2001) 1429-1437
84. Takemoto M., and Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscl Thromb Vasc Biol 21 (2001) 1712-1719
85. Ito M., Adachi T., Pimentel D.R., Ido Y., and Colucci W.S. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation 110 (2004) 412-418
86. Goldspink D.F., Burniston J.G., and Tan L.B. Cardiomyocyte death and the ageing and failing heart. Exp Physiol 88 (2003) 447-458